Riska/iStock via Getty Images
KeyBanc Capital Markets has upgraded Progyny (PGNY) to overweight from sector weight saying that the women’s health benefits company has emerging catalysts over the next 12 months.
The bank has a $30 price target (~26% upside based on Nov. 11 close).
